• English
  • 日本語
  • 中文 (中国)
ArisGlobal
  • Products
    • LifeSphere Clinical
      • LifeSphere CTMS
      • LifeSphere eTMF
      • LifeSphere EDC
      • LifeSphere eCOA
    • LifeSphere Regulatory
      • LifeSphere RIMS
      • LifeSphere Publishing
      • LifeSphere IDMP
    • LifeSphere Safety
      • LifeSphere MultiVigilance
      • LifeSphere Intake and Triage
      • LifeSphere Reporting and Analytics
      • LifeSphere Signal and Risk Management
      • LifeSphere LitPro
      • LifeSphere Reporter
      • LifeSphere EV Triage
    • LifeSphere Medical Affairs
      • LifeSphere Medical Information
      • LifeSphere Reporter
      • LifeSphere Product Complaints
    • LifeSphere EasyDocs
    • LifeSphere Nava
  • Insights
    • Blog
    • Resource Center
    • Industry Standard Practices
    • Automation in Pharmacovigilance
    • Clinical Trial Management System
    • Regulatory Information Management Platform
  • Support & Services
    • Managed Services
    • Professional Services
    • LifeSphere Trainings
    • Customer Support
  • News & Events
    • BREAKTHROUGH
    • Events
    • Press Releases
  • Our Company
    • About Us
    • Leadership Team
    • Careers
    • Environmental Social and Corporate Governance
      • Corporate Citizenship
  • Request a Demo
  • Contact Us
Select Page
Optimizing Adverse Event Reconciliation in Medical Affairs

Optimizing Adverse Event Reconciliation in
Medical Affairs

by Ethan Roberson | Mar 25, 2021 | Medical Affairs Webinar

Optimizing Adverse Event Reconciliation in Medical Affairs

Opportunities for Improved Safety Data Collection from
PSPs

by Ethan Roberson | Mar 25, 2021 | Medical Affairs Webinar

Recent Posts

  • How to Manage BREXIT Changes with LifeSphere RIMS
  • New Regulatory Capabilities Position ArisGlobal for Future Growth, Report Says
  • Delivering on the Promise of Automation in Pharmacovigilance
  • Unified Development
    Platforms

  • Accelerating Vaccine Pharmacovigilance

Recent Comments

    About ArisGlobal®

    ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

    Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

    Quick Links

    • Home
    • Company Details
    • Blog
    • Press Releases
    • Careers
    • Contact Us
    • Customer Support

    Products

    • Clinical
    • Regulatory
    • Safety
    • Medical Affairs
    • Nava
    • EasyDocs

    Services

    • Professional Services
    • Managed Services
    • LifeSphere Trainings
    • Facebook
    • Twitter
    • Instagram
    • RSS

    Designed by Elegant Themes | Powered by WordPress